The findings overall help understand how PTH1R mutations located on either the extracellular or intracellular portion of the receptor can lead to either GOF or LOF effects on ligand-dependent and -independent signaling and hence result in the variable clinical phenotypes seen in these Eiken syndrome cases. The gene discussed is PTH1R; the disease is Eiken syndrome.